Earlier this year, the FDA released draft guidance endorsing Bayesian methods and simulation-based evidence in clinical ...
UK Prime Minister Andy Burnham, who lost his father to Alzheimer's disease last week, has been urged to implement a ...
Iambic Therapeutics, which specialises in applying AI to drug discovery and development, has filed for an IPO on the Nasdaq, shortly after adding AbbVie to its roster of pharma pa ...
An adjuvanted, trivalent influenza vaccine developed by CSL Seqirus and recently approved in the UK, Aujemflu, will be deployed ahead of the 2027/28 flu season under an agreement with the government.
A consumer advocacy group has scrutinised some of the Most Favoured Nation (MFN) pricing deals the Trump administration has ...
US President Donald Trump has nominated White House health policy aide Heidi Overton to take up the mantle of commissioner for the Food and Drug Administration (FDA), ending months of speculation over ...
Sanofi is laying off 229 former Blueprint Medicines employees in Cambridge, MA and closing two legacy Blueprint facilities. The news comes just over a year after Sanofi's $9 billion acquisition of ...
The UK government has published a list of the best- and worst-performing NHS trusts in England for the first time, part of a drive to end the 'postcode lottery' of care. Health Secretary Wes Streeting ...
ADARx Pharmaceuticals, a San Diego-based biotech developing siRNA therapies for various diseases, has announced the terms for ...
Beacon Therapeutics is preparing to file for approval of its gene therapy for eye disorder X-linked retinitis pigmentosa ...
Facing considerable pressure in its diabetes and obesity franchises, Novo has revealed a plan to launch five or more ...
Adding ITM will also give Telix a pipeline of follow-up radiopharma candidates, including clinical-stage diagnostics and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results